Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.84 USD | +5.38% | +6.67% | +33.33% |
07/05 | Cogent Biosciences Q1 Loss Widens | MT |
07/05 | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.33% | 711M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Needham Starts Cogent Biosciences With Buy Rating, Price Target is $24